No Data
No Data
Express News | Sonoscape Medical Corp.: Net income is expected to decrease by 59.95%–70.07% year-on-year in 2024.
Open Healthcare: 2024 Annual Results Forecast
Sonoscape Medical Corp. (300633): Domestic equipment procurement is gradually recovering. Bullish on the company's leadership in import substitution.
Domestic leader in Medical Devices: Sonoscape Medical Corp. was established in 2002, with current main products including medical ultrasound diagnostic equipment, digestive and respiratory endoscopes, minimally invasive surgical products, and cardiovascular interventional products, among which ultrasound and flexible endoscope products lead in domestic market share (
CICC Starts SonoScape Medical at Outperform With 41.60 Yuan Price Target
Sonoscape Medical Corp. (300633): Entering a platform-type development model, innovative investments contribute to long-term momentum.
Investment highlights cover Sonoscape Medical Corp. (300633) for the first time, giving it an outperform industry rating with a target price of 41.60 yuan. Based on the DCF valuation method, the company is a leading player in the domestic ultrasound and endoscope industry. Reasons are as follows: Ultrasound Sector: The demand side or
Express News | Ping An Securities Pharmaceutical Industry 2025 Annual Strategy Report: Exploring new growth from payment sources, focusing on innovation, going overseas, equipment upgrades, and Consumer recovery.
No Data